Allergan Poised to Pay More Than $2 Billion in Opioid Settlement

AbbVie Inc.’s Allergan unit has reached an agreement to pay more than $2 billion to resolve thousands of lawsuits filed by state and local governments over the marketing of its Kadian opioid painkiller, according to people familiar with the matter.

The deal would settle more than 3,000 lawsuits brought by government entities seeking to recoup expenses from the havoc caused by opioids in their communities. Complete terms of the settlement -- such as the time period of the payout and a list of internal Allergan documents to be made public -- are still being hammered out, according to the ...